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During development, multicellular organisms must become sexually mature in order to
reproduce. The developmental timing of this transition is controlled by pulses of steroid
hormones, but how these pulses are generated have remained unclear? A recent paper
shows that in Drosophila larvae, nucleocytoplasmic trafﬁcking of DHR4, a nuclear receptor,
in response to prothoracicotropic hormone signaling, is critical for producing the correct
temporal pulses of steroid hormones that coordinate the juvenile–adult transition.
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In many animals reaching a species-speciﬁc size induces a devel-
opmental switch from juvenile growth to reproductive maturity.
This transition occurs when a developmental timing program is
aligned with permissive checkpoint signals, such as nutritional
status and photoperiod, to activate a neuroendocrine circuit that
promotes steroid-induced maturation in organisms ranging from
ﬂies to humans (Dungan et al., 2006; Tennessen and Thummel,
2011).
In some insects, it is thought that attainment of a proper level
of nutrient stores, known as the critical weight, plays a major
role in activation of neuroendocrine signal(s) that trigger meta-
morphosis, a process that produces a reproductively mature adult
(McBrayer et al., 2007; Mirth and Riddiford, 2007). Although the
mechanisms for assessing size/weight are poorly understood (see
however Callier and Nijhout, 2011), the output of achieving criti-
cal weight inDrosophila correlates well with production of an early
low-level pulse of the steroid hormone ecdysone (E),∼8–10 h after
ecdysis from the second to the third instar stage. This is followed
by at least two other low-level E pulses midway through the third
instar stage, and ﬁnally by amuch larger E peak just as pupariation
commences (Warren et al., 2006; Mirth and Riddiford, 2007). The
mechanisms responsible for generating the initial critical weight-
associated pulse, and the importance of this and the other low-level
E pulses for orchestrating the proper timing of the latemajor larval
E pulse, that initiate metamorphosis, have remained quite vague.
In a recent paper published in PLoS Biology,Ou et al. (2011) begin
to provide some insight into this issue by demonstrating that the
trafﬁcking of the nuclear receptor DHR4 between the nucleus and
the cytoplasm in response to a brain-derived neuropeptide known
as prothoracicotropic hormone (PTTH) controls the dynamics of
the E peaks and the timing of metamorphosis.
PTTH SIGNALING AND METAMORPHOSIS
Previous studies in both Lepidoptera andDrosophila have demon-
strated a key role for PTTH in stimulating E production and
metamorphosis (Rybczynski, 2005; McBrayer et al., 2007). In
Drosophila, ablating the PTTHproducing neurons causes substan-
tial developmental delay in the onset of pupariation. In contrast,
over-expression of PTTH leads to the opposite phenotype, i.e.,
early onset or precocious pupariation (McBrayer et al., 2007;
Rewitz et al., 2009b). PTTH stimulates E production by binding
to its receptor Torso, a receptor tyrosine kinase, which is expressed
in prothoracic gland (PG) cells, the endocrine tissue of the larva
responsible for E production. Torso activates the Ras/Raf/Mek
pathway resulting in the phosphorylation and targeting of phos-
phorylated Erk (pErk) to the nucleus. Interestingly, expression of
an activated form of Ras in the PG induces precocious puparia-
tion similar to what is seen when PTTH is expressed ubiquitously
(Rewitz et al., 2009b).
DHR4 IS A KEY MEDIATOR OF PTTH SIGNALING AND IS
ESSENTIAL TO PREVENT PREMATURE METAMORPHOSIS
A major block to a more comprehensive understanding of how
the PTTH signal stimulates E production in the PG and times
the onset of metamorphosis has been the lack of knowledge
concerning downstream mediators of pathway activity, especially
potential transcription factors that are targets for phosphorylation
by Erk. Previous work on the nuclear receptor DHR4 had shown
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that larvae carrying mutations in this gene undergo precocious
maturation, reducing the juvenile growth period and producing
small animals (King-Jones et al., 2005) similar to that caused by
hyper-activating PTTH signaling. Importantly, Ou et al. (2011)
demonstrated that the developmental timing defects exhibited by
DHR4 mutants are phenocopied by speciﬁc loss of DHR4 in the
PG cells and not by knockdown of DHR4 in the fat body, another
tissue inwhichDHR4 shows strong expression.These observations
led to the question of whether there might be a functional connec-
tion between PTTH signaling and DHR4 activity. As illustrated
in Figure 1, they discovered a very interesting inverse correla-
tion between PTTH mediated Erk nuclear localization and the
subcellular distribution of DHR4 in the PG cells. In the absence
FIGURE 1 | Prothoracicotropic hormone/DHR4 generate cyclic steroid
pulses that drive directional developmental transitions. A model
illustrating the mechanisms generating 8–16 h ultradian steroid oscillations.
(A) Each cycle is initiated by the release of PTTH from terminals of brain
neurons that activates the Ras pathway in the PG. This results in the
phosphorylation and nuclear localization of pERK and translocation of DHR4
to the cytoplasm, which derepresses ecdysone biosynthesis. (B) In the
presence of PTTH, the DHR4 repressor is displaced from promoters,
including Cyp6t3 increasing its expression. During periods without PTTH
signaling, nuclear DHR4 represses gene expression, although DHR4 may
act as an activator in some cases. pErk, phospho-ERK; PG, prothoracic
gland; PRE, PTTH response element; PTTH, prothoracicotropic hormone.
Torso: the transmembrane PTTH receptor in the PG. Dashed arrows
indicate inactive mechanisms.
of PTTH signaling, DHR4 was found primarily in the nucleus,
while constitutive PTTH signaling resulted in mainly cytoplasmic
DHR4. While it was not shown that Erk directly phosphorylates
DHR4, this seems highly likely since simple inspection of the
DHR4 primary sequence reveals the presence of several consensus
Erk phosphorylation sites.
The inverse correlation of Erk and DHR4 nuclear localization
suggests that the primary role of nuclear DHR4 in the PG is to
dampen the PTTH signal to prevent early metamorphosis. This
hypothesis was conﬁrmed with an epistasis experiment where
over-expression of DHR4 in the PG was found to suppress the
early pupation phenotype of activated Ras expression in the PG.
Furthermore,using carefully timed heat shock pulse-drivenDHR4
RNAi, the authors were able to demonstrate that the crucial time
at which DHR4 is required to prevent precocious metamorpho-
sis is around the time of the early third instar when the critical
weight and the low-level E pulses are determined. Intriguingly,
they found that in DHR4-depleted larvae, the E titer rose faster
and did not decline as in the controls leading to a step-like appear-
ance in the E titer proﬁle instead of a discrete pulse. Taken together,
these data indicate that DHR4 is a key target of PTTH signaling
in the PG and provide the ﬁrst compelling evidence that the small
early third instar E peak is essential for setting the tempo of larval
development.
Cyp6t3: A KEY ECDYSONE BIOSYNTHETIC COMPONENT AND
TARGET OF DHR4 REPRESSION?
The observation that PTTH signaling appears to upregulate E
titers by removing DHR4 from the nucleus leads to the obvious
questions of what genes DHR4 regulates and how they impact E
synthesis or degradation? To begin to address this question, Ou
et al. (2011) used a microarray approach in which they speciﬁ-
cally isolated RNA from carefully timed wildtype Drosophila ring
glands, a tissue that contains the PG cells, and compared the
proﬁles to similarly timed glands in which the level of DHR4
expression was reduced by RNAi knockdown. This technically
demanding experiment was able to identify a small number of
genes (∼50) that showed either enhanced or reduced expression
upon loss-of-DHR4 function. The most interesting among these,
with respect to E metabolism, were several Cyp gene family mem-
bers that code for P450 enzymes of which several are required for
either synthesis or degradation of E (Gilbert and Warren, 2005;
Rewitz et al., 2010). Intriguingly, none of the known E biosyn-
thetic P450s showed much change in expression in response to
loss-of-DHR4 function, at least not at the time points that were
examined. However, two members of the Cyp6 family, including
Cyp6t3, showed signiﬁcant upregulation upon DHR4 depletion.
The authors focused their analysis on Cyp6t3 since its expres-
sion was restricted to the ring gland and showed oscillations
that correspond to the nucleocytoplasmic oscillations of DHR4.
Knockdown of Cyp6t3 in the PG was found to produce E deﬁ-
ciency phenotypes that could be rescued by feeding larvae E or
one of several E biosynthetic precursors. These experiments tenta-
tively place Cyp6t3, along with Spook, another P450, and Shroud
a short chain dehydrogenase, at the mysterious “black box” step
that catalyzes conversion of 7-dehydrocholesterol to diketol by an
unknown mechanism. Lastly, epistasis experiments showed that
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upregulation of Cyp6t3 contributes to the developmental timing
defect ofDHR4 loss since knockdownofCyp6t3 in aDHR4 mutant
background suppressed the precocious pupation phenotype.
Despite these compelling ﬁndings suggesting a key role for
Cyp6t3 as a new E biosynthetic component, there are some puz-
zling aspects. First, Cyp6t3 shows no strong conservation among
insects, which is unusual, compared to the hitherto characterized
E biosynthetic enzymes. For Cyp6t3 there are numerous related
Cyp family members in different insect species, however, they are
not clear orthologs as can be found for all the other key Cyp E
biosynthetic enzymes. Further de novo synthesis of E is required
for embryogenesis and oogenesis. While the expression of Cyp6t3
in ovaries and embryos was not reported, data available through
the Flybase does not support much expression in these tissues,
although it may be very low as is observed in the PG. A full analy-
sis of the null mutant phenotype will be necessary to address a
possible role in embryogenesis and either clonal or RNAi knock-
down in follicle cells to address a role in ovaries. Even if cyp6t3
is not required for E biosynthesis in either of these tissues, this
might once again simply reﬂect a division of labor with a related
Cyp6 family member that is expressed during embryogenesis and
in the ovary. In fact, this same situation occurs for Spook and
Spookier, two essential ecdysteroidogenic P450s which, interest-
ingly enough, are also implicated at the black box step. In this case,
spook is expressed in embryos and ovaries and its function is dis-
pensable in larvae, while spookier is expressed in the larval PG and
its function is not required in embryos and presumably the ovary
as well. However, in this example Spook and Spookier are clear
paralogs; no similarly related Cyp6 relatives exist in Drosophila. A
third issue is the very low-level expression of Cyp6t3 in the PG.
As the authors suggest, this may indicate that Cyp6t3 is one of the
rate-limiting factors for E production, but over-expression did not
accelerate development as might be expected if this was the case.
Thus, although these experiments strongly implicate Cyp6t3 in E
biosynthesis, additional experiments to clarify its precise biochem-
ical activity are needed to fully understand its role in regulating
the E concentration.
WHAT’S NEXT?
Thework described byOu et al. (2011) undoubtedly demonstrates
that DHR4 is an important component of the network regulating
the timing of the steroid cues that drive the gene circuit under-
lying time-directional development in Drosophila. Like all good
breakthroughs however, the reported experiments raise as many
interesting questions as they answer. For example, what aspect
of the altered E titer proﬁle in DHR4 mutants is key to accelerat-
ing development? Is it themore rapid kinetics of its production, its
higher plateau level, or lack of decline that is important? Also, does
DHR4 affect the oscillation of the two subsequent low-level third
instar E peaks as well as the large late major larval peak, and if so,
do these also act as timing signals or provide some other function
such as behavioral switches? Perhaps this can be addressed using
additional andmore reﬁned temporal knockdown of eitherDHR4
or PTTH signaling components. Indeed, the whole issue of how
the ultradian cycles in Erk/DHR4 nuclear localization are timed
is something that needs to be examined. While previous work has
shown that PTTH transcription cycles with an 8-h periodicity,
the Erk/DHR4 nuclear cycles and the third instar E pulses are not
in synchrony with an 8-h periodicity, with the exception of the
ﬁrst small E pulse (McBrayer et al., 2007). Clearly, some other
process besides PTTH transcription is setting the rhythmicity of
PTTH/DHR4 signaling.
How DHR4 nucleocytoplasmic cycling is accomplished is also
unclear. As the authors point out, simply shuttling a stable DHR4
out of the nucleus in response to PTTH signaling would not
seem to be consistent with the ability to induce rapid phenotypes
by RNAi. The alternative is that nuclear DHR4 degradation is
enhanced by PTTH signaling, and its reuptake into the nucleus
is inhibited until the PTTH signal is terminated. In this regard
it would be interesting to determine if removal of DHR4 from
the nucleus provides negative feedback to terminate the PTTH
signal perhaps by inducing phosphatases that dephosphorylate
components of the Raf/Mek/Erk pathway. In the Manduca PG, for
example, ERK levels decline after 1-h of continuous exposure to
PTTH (Rybczynski et al., 2001; Rewitz et al., 2009a). Simply mon-
itoring the Erk nuclear residence time inDHR4 knockdown larvae
might help address this possibility.
One last interesting experimentwould be to examine the conse-
quence of double RNAi-mediated knock down of both torso and
DHR4 in the PG which would presumably result in the loss of
both Erk and DHR4 cycling. Upon initial reﬂection, it might seem
that this manipulation would have to affect timing since, presum-
ably, the large late-larval E peak would not occur in the absence of
PTTH. However, the answer might be surprising if, for example,
there was a steady increase in E in the double RNAi larvae, perhaps
simply as the result of gland growth, and the larvae were able to
integrate the total E signal over time. There is precedence for this
ability in Manduca, where a prolonged continuous small E dose
can have the same effect as a larger pulsed dose (Nijhout, 1976).
Signal integration of a steady E ramp up may enable the larvae
to still initiate metamorphosis with close to normal timing. The
results by Ou et al. (2011) provide important insights into reg-
ulation of the steroid pulse generator that, from an evolutionary
perspective, seems to be a key part of the neuroendocrine system
coordinating the juvenile–adult transition in animals.
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